In immunocompromised individuals, EBV serves as a key driver of lymphomagenesis through viral oncoproteins (LMP1 and LMP2A), which activate essential survival signaling pathways such as NF-κB, reshape the tumor microenvironment, and facilitate immune evasion. The gene discussed is PDLIM7; the disease is neoplasm.